Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.
Beneficial effects of integrin αvβ3-blocking RGD peptides in early but not late phase of experimental glomerulonephritis.
K. Amann,C. Haas,3 Authors,H. Schöcklmann
2012 · DOI: 10.1093/ndt/gfr603
Nephrology, Dialysis and Transplantation · 17 Citations
TLDR
Habu GN inhibition of integrin αvβ3 by cRGD partly ameliorates early injury but has no or only mild effects on late glomerular lesions.